Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.14% | -487.90% | 20.73% | -18.62% | -15.42% |
| Total Depreciation and Amortization | 11.11% | 3.64% | -8.06% | -1.72% | -5.26% |
| Total Amortization of Deferred Charges | 15.38% | -14.29% | -14.29% | -21.43% | 44.44% |
| Total Other Non-Cash Items | -107.07% | 2,039.10% | -141.76% | -16.42% | 28.53% |
| Change in Net Operating Assets | 545.06% | -88.07% | 726.82% | -441.25% | 249.12% |
| Cash from Operations | 26.25% | -18.83% | 37.48% | -95.64% | -9.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.16% | -2,155.62% | 25.75% | -93.96% | -195.35% |
| Cash from Investing | 86.90% | -2,155.86% | 25.75% | -93.95% | -195.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 480.31% | 308.66% | -- | 85.19% | 2,108.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 433.92% | 308.66% | -- | 818.33% | 149.83% |
| Foreign Exchange rate Adjustments | -200.00% | 50.00% | 50.00% | 500.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.98% | -48.84% | 2,700.00% | -442.82% | -282.66% |